Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Apr 11;316(7138):1140-6.
doi: 10.1136/bmj.316.7138.1140.

The role of nuclear medicine in clinical investigation

E M Prvulovich  1 , J B Bomanji
Affiliations
Review

The role of nuclear medicine in clinical investigation

E M Prvulovich et al. BMJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
201Tl myocardial perfusion images in a patient with exertional chest pain. Reversible ischaemia of the anterior, inferior, and lateral walls suggests a high probability of future cardiac events
Figure 3
Figure 3
99mTc-MDP bone scan in a patient with carcinoma of the prostate and pelvic pain. Multiple focal areas of increased tracer activity throughout the skeleton (including the pelvis, spine, ribs, skull, and femurs) indicate widespread bony metastases
Figure 2
Figure 2
Ventilation-perfusion lung scan (left posterior oblique views: (left) ventilation; (right) perfusion) in a patient with dyspnoea and pleuritic chest pain. There are multiple perfusion defects which are ventilated. High probability of pulmonary embolism
Figure 2
Figure 2
Ventilation-perfusion lung scan (left posterior oblique views: (left) ventilation; (right) perfusion) in a patient with dyspnoea and pleuritic chest pain. There are multiple perfusion defects which are ventilated. High probability of pulmonary embolism
Figure 4
Figure 4
99mTc-MDP bone scan of painful legs in athlete. Elongated focus of increased activity along posterior third of tibial shaft is typical of shin splint
Figure 5
Figure 5
99mTc-MAG3 renogram in patient with stent inserted for right pelvi-ureteric obstruction. Right kidney shows sluggish tracer excretion. No significant drainage even after 40 mg frusemide was given, compatible with right obstructive uropathy
Figure 6
Figure 6
99mTc-DMSA scan (posterior view) in patient with recurrent urinary tract infection. Cortical defects (arrows) at upper pole and lateral margin of left kidney indicate scarring
Figure 7
Figure 7
111In white cell study (anterior view) in patient with newly diagnosed Crohn’s disease. Increased tracer activity in ileocaecal region and entire colon indicates diffuse active inflammatory bowel disease
Figure 8
Figure 8
99mTc-pertechnetate Meckel’s scan (anterior view) in patient with gastrointestinal bleeding. Increased tracer activity within Meckel’s diverticulum (arrow); normal tracer uptake in stomach and adjacent right renal pelvis
Figure 9
Figure 9
123I scan in patient with thyroid swelling. Irregular tracer uptake in enlarged multinodular thyroid gland; dominant “cold” area in left thyroid lobe (arrow). Subsequent biopsy showed colloid cyst
Figure 10
Figure 10
(left) 123I-MIBG scan in patient with malignant carcinoid and liver metastases to assess suitability for treatment with 131I-MIBG. Several areas of intense tracer uptake in liver, particularly within right lobe (two medium arrows) and pelvis (small arrow) to left of bladder (open arrow). 123I-MIBG avid carcinoid metastases suitable for 131I-MIBG therapy Fig 11 (right) 131I follow up scan in patient with differentiated carcinoma of thyroid. Multiple focal areas of increased tracer uptake (including skull, left cervical nodes, lungs, lower abdomen, femurs). 131I avid carcinoma thyroid metastases suitable for radioiodine therapy
Figure 10
Figure 10
(left) 123I-MIBG scan in patient with malignant carcinoid and liver metastases to assess suitability for treatment with 131I-MIBG. Several areas of intense tracer uptake in liver, particularly within right lobe (two medium arrows) and pelvis (small arrow) to left of bladder (open arrow). 123I-MIBG avid carcinoid metastases suitable for 131I-MIBG therapy Fig 11 (right) 131I follow up scan in patient with differentiated carcinoma of thyroid. Multiple focal areas of increased tracer uptake (including skull, left cervical nodes, lungs, lower abdomen, femurs). 131I avid carcinoma thyroid metastases suitable for radioiodine therapy
Figure 12
Figure 12
111In-pentetreotide scan in patient with malignant carcinoid and liver metastases proved by biopsy not seen on abdominal spiral computed tomography scan. Normal distribution of 111In-pentetreotide to spleen (large arrow) and kidneys (K); small focal area of increased tracer activity in right lobe of liver (small arrow on right), indicating lesion positive for somatostatin receptor
See this image and copyright information in PMC

References

    1. Pennell DJ, Prvulovich EM. Clinician’s guide to nuclear medicine: nuclear cardiology. Hatfield: Impact Healthcare; 1995.
    1. McKillop JH, Fogelman I. Clinician’s guide to nuclear medicine: benign and malignant bone disease. London: Churchill Livingstone; 1991.
    1. Testa HJ, Prescott MC. Clinician’s guide to nuclear medicine: nephrourology. Hatfield: Impact Healthcare; 1996.
    1. Harding LK, Robinson PJA. Clinician’s guide to nuclear medicine: gastroenterology. London: Churchill Livingstone; 1990.
    1. Costa DC, Ell PJ. Clinician’s guide to nuclear medicine: blood flow in neurology and psychiatry. London: Churchill Livingstone; 1991.

MeSH terms